|1.||Moroz, V V: 6 articles (05/2004 - 01/2000)|
|2.||Abdullaev, I A: 3 articles (04/2014 - 01/2014)|
|3.||Abusuev, A A: 2 articles (01/2008 - 11/2002)|
|4.||Askerkhanov, G R: 2 articles (01/2007 - 01/2000)|
|5.||Romanova, T V: 2 articles (01/2007 - 10/2004)|
|6.||Zorin, N A: 2 articles (01/2007 - 10/2004)|
|7.||Moiseeva, L M: 2 articles (01/2007 - 10/2004)|
|8.||Konysheva, T V: 2 articles (01/2007 - 10/2004)|
|9.||Lykova, O F: 2 articles (01/2007 - 10/2004)|
|10.||Aliev, O M: 2 articles (05/2004 - 11/2002)|
01/01/2000 - "For higher efficacy of general purulent peritonitis treatment, intraperitoneal perfusion of Perftoran emulsion was proposed. "
12/01/2003 - "Experimental study of the use of Perftoran for preventing the formation of postoperative adhesions in peritonitis."
01/01/2014 - "[Effect on performance ozonized perftoran cytokine profile in generalized peritonitis]."
01/01/2014 - "[Application of ozonated perftoran in the treatment of spreaded peritonitis]."
01/01/2009 - "Analysis of results of treatment of 51 patients with diffuse peritonitis has shown effectiveness of correction of disturbed microcirculation in the intestine by means of administration of oxygenic perftoran."
|2.||Periodontal Diseases (Periodontal Disease)
01/01/2005 - "As it was shown in the clinical study local use of perftoran in patients with periodontal disease led to significant reduction of lipid peroxidation (LPO) and significant increase of antioxidant activity (AOA) in saliva. "
01/01/2005 - "[Perfluorine (perftoran) influence on lipid peroxidation and salivary antioxidant activity in patients with periodontal disease]."
01/01/2008 - "[Perftoran in complex therapy of acute myocardial infarction in elderly patients]."
05/01/2004 - "[Changes in the cardiac hemodynamics and coronary blood flow in acute myocardial infarction due to perftoran]."
11/01/2002 - "[Perftoran infusion in acute myocardial infarction]."
01/01/2008 - "The obtained results prove that timely application of combined therapy by streptase and perftoran in complex treatment of acute myocardial infarction in elderly patients promotes efficacy of the treatment."
01/01/2008 - "220 elderly patients with acute myocardial infarction were examined; 93 of them were given standard thrombolytic therapy, 62 patients were given perftoran and 65 patients were given combined therapy by streptase and perftoran. "
|4.||Congenital Heart Defects (Congenital Heart Defect)
|5.||Wounds and Injuries (Trauma)
11/01/2003 - "The application of perftoran in the early post-trauma period was found to intensify the processes of lipid peroxidation and, simultaneously, to normalize the parameters of the antioxidant-protection system."
11/01/2003 - "[Effect of perftoran on the oxidant-antioxidant system in patients with severe trauma and blood loss]."
05/01/2001 - "[Effect of perftoran on morphology and rheologic properties of erythrocytes in patients with severe trauma and blood loss]."
01/01/1997 - "Perftoran has no necrolytic and antibacterial properties and fails to make the terms of the 1st phase of the wound process shorter. "
01/01/1997 - "The article shows effectiveness of the local application of Perftoran in complex treatment of purulent wounds of soft tissues in 50 patients. "
|3.||erythrocyte receptor (sialoadhesin)
|4.||Blood Substitutes (Artificial Blood)
|8.||Sodium Chloride (Saline Solution)
|9.||Pulmonary Surfactants (Pulmonary Surfactant)
|10.||Methyl Parathion (Dalf)
|2.||Artificial Liver (Bioartificial Liver)
|3.||Intensive Care (Surgical Intensive Care)